PERSIA HADAD: Open Payments
NPI 1760156095 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,037 in 91 payments from 19 companies in 2025. Trend: 2023 $2,256 · 2024 $3,133 · 2025 $2,037
Food & beverage: $2,037
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $508 |
| ABBVIE INC. | 13 | $340 |
| Lilly USA, LLC | 7 | $152 |
| GENZYME CORPORATION | 6 | $128 |
| Regeneron Healthcare Solutions, Inc. | 6 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $96 |
| Intercept Pharmaceuticals, Inc. | 5 | $92 |
| Celltrion USA Inc. | 4 | $91 |
| Phathom Pharmaceuticals, Inc. | 7 | $89 |
Products named: TREMFYA, DUPIXENT, RINVOQ, OMVOH, XIFAXAN, OCALIVA, VEGZELMA, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
